California Compounding Company, Inc.

Pharmaceuticals · LOS ANGELES, CA

PharmaceuticalsSEC Form D

California Compounding Company, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 12, 2026, reporting $4,923,273 raised toward a $14,520,001 offering.

Incorporated in Delaware and based in LOS ANGELES, CA, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that California Compounding Company, Inc. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Justin LyleExecutive Officer · Director
  • Alex FerrieraExecutive Officer · Director
  • Tyler TarrExecutive Officer

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$50.0KRaised

Matthias Therapeutics, LLC

PharmaceuticalsBASKING RIDGE, NJ
May 14, 2026View SEC Form D
$5.3MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 11, 2026View SEC Form D
$2.5MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 8, 2026View SEC Form D
$22.5MRaised

CNS Pharmaceuticals, Inc.

PharmaceuticalsHOUSTON, TX
May 4, 2026View SEC Form D
$100.0KRaised

PharmassetX Inc.

PharmaceuticalsLOUISVILLE, KY
Apr 30, 2026View SEC Form D
California Compounding Company, Inc. raised $4.9M — SEC Form D